PIK3CA and gastric cancer: A previous study [19] reported that patients with PIK3CA amplifications were associated with more peritoneal recurrence than those without PIK3CA amplifications in GC, which was similar to the findings of the present study (16.5% vs. 9.8%, p = 0.036).